Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8059 ARTÍCULOS , VIENDO DEL 5986 AL 6000

Cellular protection and therapeutic potential of tocotrienols

Catalgol B, Batirel S, Ozer NK.

Curr Pharm Des. 2011;17(21):2215-20. doi: 10.2174/138161211796957436.

Recent developments of functional magnetic resonance imaging research for drug development in Alzheimer's disease

Hampel H, Prvulovic D, Teipel SJ, Bokde AL.

Prog Neurobiol. 2011 Dec;95(4):570-8. doi: 10.1016/j.pneurobio.2011.05.012. Epub 2011 Jul 13.

Amyloid-related imaging abnormalities in amyloid-modifying therapeutic trials: recommendations from the Alzheimer's Association Research Roundtable Workgroup

Sperling RA, Jack CR Jr, Black SE, Frosch MP, Greenberg SM, Hyman BT, Scheltens P, Carrillo MC, Thies W, Bednar MM, Black RS, Brashear HR, Grundman M, Siemers ER, Feldman HH, Schindler RJ.

Alzheimers Dement. 2011 Jul;7(4):367-85. doi: 10.1016/j.jalz.2011.05.2351.

Traditional Chinese medicines and Alzheimer's disease

Wu TY, Chen CP, Jinn TR.

Taiwan J Obstet Gynecol. 2011 Jun;50(2):131-5. doi: 10.1016/j.tjog.2011.04.004.

Recent advances in the multitarget-directed ligands approach for the treatment of Alzheimer's disease

León R, Garcia AG, Marco-Contelles J.

Med Res Rev. 2013 Jan;33(1):139-89. doi: 10.1002/med.20248. Epub 2011 Jul 26.

Increasing walking and bright light exposure to improve sleep in community-dwelling persons with Alzheimer's disease: results of a randomized, controlled trial

McCurry SM, Pike KC, Vitiello MV, Logsdon RG, Larson EB, Teri L.

J Am Geriatr Soc. 2011 Aug;59(8):1393-402. doi: 10.1111/j.1532-5415.2011.03519.x. Epub 2011 Jul 28.

[Profile of the informal carer associated with the clinical management of the Alzheimer's disease patient refractory to symptomatic treatment of the disease]

Molinuevo JL, Hernández B; Grupo de Trabajo del Estudio IMPACT.

Neurologia. 2011 Nov;26(9):518-27. doi: 10.1016/j.nrl.2011.05.011. Epub 2011 Jul 30.

Pharmacologists and Alzheimer disease therapy: to boldly go where no scientist has gone before

Mancuso C, Siciliano R, Barone E, Butterfield DA, Preziosi P.

Expert Opin Investig Drugs. 2011 Sep;20(9):1243-61. doi: 10.1517/13543784.2011.601740. Epub 2011 Aug 2.

Pharmacological study on Alzheimer's drugs targeting calcium/calmodulin-dependent protein kinase II

Moriguchi S.

J Pharmacol Sci. 2011;117(1):6-11. doi: 10.1254/jphs.11r06cp. Epub 2011 Aug 6.

Berberine: a potential multipotent natural product to combat Alzheimer's disease

Ji HF, Shen L.

Molecules. 2011 Aug 9;16(8):6732-40. doi: 10.3390/molecules16086732.

Unbiased comparison of sample size estimates from longitudinal structural measures in ADNI

Holland D, McEvoy LK, Dale AM; Alzheimer's Disease Neuroimaging Initiative.

Hum Brain Mapp. 2012 Nov;33(11):2586-602. doi: 10.1002/hbm.21386. Epub 2011 Aug 9.

Recent approaches targeting beta-amyloid for therapeutic intervention of Alzheimer's disease

Cho JE, Kim JR.

Recent Pat CNS Drug Discov. 2011 Sep 1;6(3):222-33. doi: 10.2174/157488911796958002.

A pilot usability study of MINWii, a music therapy game for demented patients

Boulay M, Benveniste S, Boespflug S, Jouvelot P, Rigaud AS.

Technol Health Care. 2011;19(4):233-46. doi: 10.3233/THC-2011-0628.

New drugs for Alzheimer's disease in Japan

Takeda M, Tanaka T, Okochi M.

Psychiatry Clin Neurosci. 2011 Aug;65(5):399-404. doi: 10.1111/j.1440-1819.2011.02253.x.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias